Median Tech debuts AI-focused unit for cancer trial support
pharmaphorum
JUNE 1, 2022
Medical imaging specialist Median Technologies has launched a new business unit that will provide decision-making tools – underpinned by artificial intelligence – for sponsors of clinical trials in oncology. Bringing a new cancer drug to market costs an average of $2.8
Let's personalize your content